Mc Adam, LLC Vertex Pharmaceuticals Inc Transaction History

Mc Adam, LLC

$1.77 Billion
Q3 2024

A detailed history of Mc Adam, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mc Adam, LLC holds 2,636 shares of VRTX stock, worth $1.32 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,636

Previous 2,520 4.6%

Holding current value

$1.32 Million

Previous $1.18 Million 3.73%

% of portfolio

0.07%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$460.0 - $505.78 $53,360 - $58,670	116 Added 4.6%	2,636 $1.23 Million
Q2 2024 Jul 24, 2024	BUY	$392.81 - $485.53 $191,691 - $236,938	488 Added 24.02%	2,520 $1.18 Million
Q1 2024 Apr 23, 2024	BUY	$407.69 - $446.08 $14,269 - $15,612	35 Added 1.75%	2,032 $849,000
Q4 2023 Feb 05, 2024	SELL	$343.0 - $410.68 $58,310 - $69,815	-170 Reduced 7.84%	1,997 $812,000
Q3 2023 Oct 31, 2023	BUY	$338.18 - $362.46 $1,352 - $1,449	4 Added 0.18%	2,167 $753,000
Q2 2023 Aug 02, 2023	SELL	$314.42 - $351.91 $18,865 - $21,114	-60 Reduced 2.7%	2,163 $761,000
Q1 2023 Apr 24, 2023	SELL	$283.23 - $323.1 $207,041 - $236,186	-731 Reduced 24.75%	2,223 $700,000
Q4 2022 Jan 27, 2023	BUY	$285.76 - $321.48 $53,151 - $59,795	186 Added 6.72%	2,954 $649,000
Q3 2022 Oct 24, 2022	BUY	$273.83 - $305.53 $1,369 - $1,527	5 Added 0.18%	2,768 $801,000
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $39,943 - $49,733	-170 Reduced 5.8%	2,763 $779,000
Q1 2022 Apr 07, 2022	SELL	$221.42 - $260.97 $4,649 - $5,480	-21 Reduced 0.71%	2,933 $765,000
Q4 2021 Jan 07, 2022	SELL	$177.01 - $223.45 $68,148 - $86,028	-385 Reduced 11.53%	2,954 $649,000
Q3 2021 Oct 05, 2021	BUY	$181.39 - $202.99 $257,392 - $288,042	1,419 Added 73.91%	3,339 $606,000
Q2 2021 Aug 02, 2021	BUY	$187.49 - $221.1 $39,372 - $46,431	210 Added 12.28%	1,920 $385,000
Q4 2020 Jan 12, 2021	BUY	$207.01 - $276.09 $140,559 - $187,465	679 Added 65.86%	1,710 $401,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $2,556 - $3,031	10 Added 0.98%	1,031 $281,000
Q2 2020 Jul 31, 2020	SELL	$225.48 - $295.8 $7,666 - $10,057	-34 Reduced 3.22%	1,021 $296,000
Q1 2020 May 08, 2020	BUY	$199.77 - $247.81 $6,792 - $8,425	34 Added 3.33%	1,055 $251,000
Q4 2019 Jan 23, 2020	BUY	$166.71 - $223.91 $170,210 - $228,612	1,021 New	1,021 $224,000
Q3 2019 Oct 15, 2019	SELL	$166.23 - $187.09 $193,159 - $217,398	-1,162 Closed	0 $0
Q1 2019 Apr 22, 2019	SELL	$163.73 - $194.7 $17,682 - $21,027	-108 Reduced 8.5%	1,162 $214,000
Q3 2018 Oct 10, 2018	BUY	$167.73 - $192.74 $195,908 - $225,120	1,168 Added 1145.1%	1,270 $244,000
Q2 2018 Aug 22, 2018	SELL	$145.72 - $169.96 $123,570 - $144,126	-848 Reduced 89.26%	102 $17,000
Q1 2018 Apr 24, 2018	BUY	$151.6 - $177.13 $144,020 - $168,273	950 New	950 $155,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account